The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as...
13 insider purchases on record · latest filing 2011-12-16.
Insiders have also filed 26 sale transactions at GNOM.